CXCR3 and melanoma: Our results suggest that, in BRAFWT melanomas, increases in CXCR3 signaling mediates increases in IL-8 expression, and consequently, that CXCR3 may contribute to the transition from RGP to VGP in the melanoma patient population where the BRAFV600E mutation is not present.